KYTHERA BIOPHARMACEUTICALS I - COM (KYTH)

CUSIP: 501570105

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
18,596,301
Share change
+844,038
Total reported value
$713,300,853
Price per share
$38.37
Number of holders
104
Value change
+$32,037,191
Number of buys
60
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 501570105?
CUSIP 501570105 identifies KYTH - KYTHERA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) as of Q2 2014

As of 30 Jun 2014, KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,596,301 shares. The largest 10 holders included FMR LLC, JENNISON ASSOCIATES LLC, Partner Fund Management, L.P., Palo Alto Investors, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, BlackRock Fund Advisors, WADDELL & REED FINANCIAL INC, ADAGE CAPITAL PARTNERS GP LLC, State Street Corp, and Pentwater Capital Management LP. This page lists 104 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.